2024-03-28T13:28:26Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_55A027525A9C
2024-03-23T02:23:30Z
serval:BIB_55A027525A9C
Treatment landscape of metastatic pancreatic cancer.
10.1016/j.ctrv.2021.102180
000645000400002
33812339
De Dosso
S.
author
Siebenhüner
A.R.
author
Winder
T.
author
Meisel
A.
author
Fritsch
R.
author
Astaras
C.
author
Szturz
P.
author
Borner
M.
author
article
review
2021-05
Cancer treatment reviews
1532-1967
0305-7372
journal
96
102180
Albumins/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Carcinoma, Pancreatic Ductal/drug therapy
Carcinoma, Pancreatic Ductal/pathology
Carcinoma, Pancreatic Ductal/surgery
Clinical Trials, Phase III as Topic
Deoxycytidine/administration & dosage
Deoxycytidine/analogs & derivatives
Fluorouracil/administration & dosage
Humans
Irinotecan/administration & dosage
Leucovorin/administration & dosage
Liposomes/administration & dosage
Neoplasm Metastasis
Oxaliplatin/administration & dosage
Paclitaxel/administration & dosage
Pancreatic Neoplasms/drug therapy
Pancreatic Neoplasms/pathology
Pancreatic Neoplasms/surgery
Randomized Controlled Trials as Topic
Biomarkers
FOLFIRINOX
Gemcitabine
Liposomal-irinotecan
Nab-paclitaxel
Pancreatic cancer
Precision medicine
eng
60_published
peer-reviewed
Publication types: Journal Article ; Review
Publication Status: ppublish